相关实验视频
Updated: Jun 18, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.6K
患有Fallot症候群四重症的幼儿:分流还是初级修复?
Xin Tao Ye1,2,3, Soichiro Henmi4, Edward Buratto1,2,3
1Department of Cardiac Surgery, Royal Children's Hospital, Melbourne, Victoria, Australia.
JTCVS open
|July 17, 2024
概括
对于患有Fallot四重症 (TOF) 的婴儿,阶段性修复 (SR) 和初级修复 (PR) 显示出类似的心脏死亡率和重新干预率. 这两种策略在接受手术修复的有症状的婴儿中提供了可比的结果.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 生产性心脏手术 手术 生产心脏手术
- 医学成果研究研究成果
背景情况:
- 费洛特四病 (TOF) 是一种复杂的先天性心脏缺陷,需要在有症状的婴儿中进行手术.
- 最佳的手术策略,无论是分阶段修复 (SR) 还是初级修复 (PR),仍然是争论的主题.
- 两个机构对TOF维修有着不同的,独家的方法,提供了一个独特的机会来比较这些策略.
研究的目的:
- 为了比较分阶段修复 (SR) 与初级修复 (PR) 的临床结果,在患有Fallot四分法 (TOF) 的症状年幼婴儿中.
- 评估两种手术方法之间的死亡率,术后并发症,资源利用率和再干预率的差异.
主要方法:
- 进行了一项倾向分数匹配分析,将4个月以下接受SR (n=143) 和PR (n=122) 的婴儿与两个专门中心的婴儿进行比较.
- 主要结局是死亡率,次要结局包括并发症,支持持续时间,住院和重新干预.
- 随访时间中位数为8.3年,对57对匹配的队列进行了分析,以进行详细的比较.
主要成果:
- 医院死亡率和10年生存率在SR和PR组之间在初始手术后相似.
- 复杂回应组经历了更多的早期再干预,但晚期再干预率是可比的.
- 在匹配的队列中,SR表现出类似的免于重新干预的自由,但显著更高的10年生存率,归因于较少的非心脏病死亡.
结论:
- 在患有TOF的症状婴儿中,阶段性修复 (SR) 策略与与心脏相关的死亡率和再干预率相似,与初级修复 (PR) 相比,在中期随访时相似.
- 在SR和PR之间做出选择可能会受到机构协议和患者特定因素的影响.
- 进一步的研究可能会阐明长期的差异,特别是关于非心脏结果.
相关概念视频
Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Flail Chest-II
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

